Tanaka M, Spekker E, Szabo A, Polyak H, Vecsei L
J Neural Transm (Vienna). 2022; 129(5-6):627-642.
PMID: 35624406
DOI: 10.1007/s00702-022-02513-5.
Gogos A, van den Buuse M
Curr Top Behav Neurosci. 2022; 62:133-163.
PMID: 35243605
DOI: 10.1007/7854_2022_305.
Wickens M, Bangasser D, Briand L
Front Mol Neurosci. 2018; 11:197.
PMID: 29922129
PMC: 5996114.
DOI: 10.3389/fnmol.2018.00197.
Winship I, Dursun S, Baker G, Balista P, Kandratavicius L, Maia-de-Oliveira J
Can J Psychiatry. 2018; 64(1):5-17.
PMID: 29742910
PMC: 6364139.
DOI: 10.1177/0706743718773728.
Kawata M, Morikawa S, Shiosaka S, Tamura H
Transl Psychiatry. 2017; 7(3):e1052.
PMID: 28267150
PMC: 5416666.
DOI: 10.1038/tp.2017.20.
Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.
Samsom J, Wong A
Front Psychiatry. 2015; 6:13.
PMID: 25762938
PMC: 4332163.
DOI: 10.3389/fpsyt.2015.00013.
Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.
Mei L, Nave K
Neuron. 2014; 83(1):27-49.
PMID: 24991953
PMC: 4189115.
DOI: 10.1016/j.neuron.2014.06.007.
Distinct phenotypes of new transmembrane-domain neuregulin 1 mutant mice and the rescue effects of valproate on the observed schizophrenia-related cognitive deficits.
Pei J, Liu C, Lai W
Front Behav Neurosci. 2014; 8:126.
PMID: 24782733
PMC: 3995064.
DOI: 10.3389/fnbeh.2014.00126.
Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models.
Karl T
Front Behav Neurosci. 2013; 7:106.
PMID: 23966917
PMC: 3744031.
DOI: 10.3389/fnbeh.2013.00106.
Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.
Deng C, Pan B, Engel M, Huang X
Psychopharmacology (Berl). 2013; 226(2):201-15.
PMID: 23389757
DOI: 10.1007/s00213-013-3003-2.
White matter abnormalities and animal models examining a putative role of altered white matter in schizophrenia.
Xu H, Li X
Schizophr Res Treatment. 2012; 2011():826976.
PMID: 22937274
PMC: 3420616.
DOI: 10.1155/2011/826976.
Mutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathology.
Runker A, OTuathaigh C, Dunleavy M, Morris D, Little G, Corvin A
PLoS One. 2011; 6(11):e26488.
PMID: 22132072
PMC: 3221675.
DOI: 10.1371/journal.pone.0026488.
Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.
Lyon L, Saksida L, Bussey T
Psychopharmacology (Berl). 2011; 220(4):647-72.
PMID: 22068459
DOI: 10.1007/s00213-011-2536-5.
Neuroanatomical changes in a mouse model of early life neglect.
Duque A, Coman D, Carlyle B, Bordner K, George E, Papademetris X
Brain Struct Funct. 2011; 217(2):459-72.
PMID: 21984312
PMC: 3664301.
DOI: 10.1007/s00429-011-0350-9.
Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models.
Kvajo M, McKellar H, Gogos J
Neuroscience. 2011; 211:136-64.
PMID: 21821099
PMC: 3351555.
DOI: 10.1016/j.neuroscience.2011.07.051.
Sex-specific neuroendocrine and behavioral phenotypes in hypomorphic Type II Neuregulin 1 rats.
Taylor S, Markham J, Taylor A, Kanaskie B, Koenig J
Behav Brain Res. 2011; 224(2):223-32.
PMID: 21620900
PMC: 3159843.
DOI: 10.1016/j.bbr.2011.05.008.
Phenotypic characterization of transgenic mice overexpressing neuregulin-1.
Kato T, Kasai A, Mizuno M, Fengyi L, Shintani N, Maeda S
PLoS One. 2010; 5(12):e14185.
PMID: 21151609
PMC: 3000321.
DOI: 10.1371/journal.pone.0014185.
Disruption of the neuregulin 1 gene in the rat alters HPA axis activity and behavioral responses to environmental stimuli.
Taylor S, Taylor A, Markham J, Geurts A, Kanaskie B, Koenig J
Physiol Behav. 2010; 104(2):205-14.
PMID: 21092742
PMC: 3081908.
DOI: 10.1016/j.physbeh.2010.11.015.
A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice.
Long L, Chesworth R, Arnold J, Karl T
Psychopharmacology (Berl). 2010; 211(3):277-89.
PMID: 20571781
DOI: 10.1007/s00213-010-1896-6.
Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.
Wen L, Lu Y, Zhu X, Li X, Woo R, Chen Y
Proc Natl Acad Sci U S A. 2010; 107(3):1211-6.
PMID: 20080551
PMC: 2824309.
DOI: 10.1073/pnas.0910302107.